These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 26315120)
1. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties. Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120 [TBL] [Abstract][Full Text] [Related]
2. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes. Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867 [TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of ibuprofen/beta-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods. Hussein K; Türk M; Wahl MA Pharm Res; 2007 Mar; 24(3):585-92. PubMed ID: 17260160 [TBL] [Abstract][Full Text] [Related]
5. Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide. Al-Marzouqi AH; Shehatta I; Jobe B; Dowaidar A J Pharm Sci; 2006 Feb; 95(2):292-304. PubMed ID: 16372306 [TBL] [Abstract][Full Text] [Related]
6. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide. Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246 [TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
9. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
10. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Bhargava S; Agrawal GP Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. Al-Marzouqi AH; Elwy HM; Shehadi I; Adem A J Pharm Biomed Anal; 2009 Feb; 49(2):227-33. PubMed ID: 19062214 [TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation. Semalty M; Panchpuri M; Singh D; Semalty A Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
14. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems. Onyeji CO; Omoruyi SI; Oladimeji FA Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103 [TBL] [Abstract][Full Text] [Related]
15. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
16. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process. Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046 [TBL] [Abstract][Full Text] [Related]
17. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin. Ozdemir N; Ordu S Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593 [TBL] [Abstract][Full Text] [Related]
18. Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound. Van Hees T; Piel G; Evrard B; Otte X; Thunus L; Delattre L Pharm Res; 1999 Dec; 16(12):1864-70. PubMed ID: 10644075 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods. Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552 [TBL] [Abstract][Full Text] [Related]
20. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]